We are excited to announce that Zepto Life has officially started a pilot clinical study in collaboration with Mayo Clinic to evaluate our breakthrough diagnostic test for invasive fungal infections. This study represents a critical step forward in our mission to improve diagnostics and patient outcomes worldwide.
Led by Dr. Vergidis from Mayo Clinic, this pilot study will focus on assessing the efficacy of Zepto’s Fungiflex test, which aims to provide clinicians with a powerful tool to detect invasive fungal infections directly from patient blood samples. These infections, often difficult to diagnose, can lead to severe complications if not identified early. Our collaboration with Mayo Clinic underscores the importance of advancing diagnostic tools that can make a meaningful impact on patient outcomes.